The immunocytokine NHS-IL12 as a potential cancer therapeutic

被引：0
|
作者：
Fallon, Jonathan K. [1 ]
Tighe, Robert [2 ]
Lyon, Amanda J. [1 ]
Sabzevari, Helen [2 ]
Schlom, Jeffrey [1 ]
Greiner, John W. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] EMD Serono, Billerica, MA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2573
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The immunocytokine NHS-IL12 as a potential cancer therapeutic
    Fallon, Jonathan
    Tighe, Robert
    Kradjian, Giorgio
    Guzman, Wilson
    Bernhardt, Anna
    Neuteboom, Berend
    Lan, Yan
    Sabzevari, Helen
    Schlom, Jeffrey
    Greiner, John W.
    ONCOTARGET, 2014, 5 (07) : 1869 - 1884
  • [2] NHS-IL12, a Tumor-Targeting Immunocytokine
    Greiner, John W.
    Morillon, Y. Maurice
    Schlom, Jeffrey
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 155 - 169
  • [3] Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma
    Paoloni, Melissa
    Mazcko, Christina
    Selting, Kimberly
    Lana, Susan
    Barber, Lisa
    Phillips, Jeffrey
    Skorupski, Katherine
    Vail, David
    Wilson, Heather
    Biller, Barbara
    Avery, Anne
    Kiupel, Matti
    LeBlanc, Amy
    Bernhardt, Anna
    Brunkhorst, Beatrice
    Tighe, Robert
    Khanna, Chand
    PLOS ONE, 2015, 10 (06):
  • [4] Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12
    Morillon, Y. Maurice, II
    Su, Zhen
    Schlom, Jeffrey
    Greiner, John W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12
    Toney, Nicole J.
    -Mays, Margaret E. Gatti
    Tschernia, Nicholas P.
    Strauss, Julius
    Gulley, James L.
    Schlom, Jeffrey
    Donahue, Renee N.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116
  • [6] Impact of treatment-induced necrosis in the anti-tumor efficacy of Entinostat combined with the immunocytokine NHS-IL12
    Ozawa, Yohei
    Hicks, Kristin
    Knudson, Karin
    Schlom, Jeffrey
    Gameiro, Sofia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models
    Eckert, Franziska
    Schmitt, Julia
    Zips, Daniel
    Krueger, Marcel A.
    Pichler, Bernd J.
    Gillies, Stephen D.
    Strittmatter, Wolfgang
    Handgretinger, Rupert
    Schilbach, Karin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (08) : 1003 - 1013
  • [8] Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models
    Franziska Eckert
    Julia Schmitt
    Daniel Zips
    Marcel A. Krueger
    Bernd J. Pichler
    Stephen D. Gillies
    Wolfgang Strittmatter
    Rupert Handgretinger
    Karin Schilbach
    Cancer Immunology, Immunotherapy, 2016, 65 : 1003 - 1013
  • [9] Immunotherapy with NHS-IL12 in combination with local irradiation to achieve tumour control
    Eckert, F.
    Zips, D.
    Schmitt, J.
    Krueger, M. A.
    Pichler, B. J.
    Handgretinger, R.
    Schilbach, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S95 - S95
  • [10] NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models
    Xu, Chunxiao
    Marelli, Bo
    Qi, Jin
    Qin, Guozhong
    Yu, Huakui
    Wang, Hong
    Jenkins, Molly H.
    Lo, Kin-Ming
    Lan, Yan
    TRANSLATIONAL ONCOLOGY, 2022, 16
12345